Fig. 2From: Evaluation of disease burden and response to treatment in adults with type 1 gaucher disease using a validated disease severity scoring system (DS3)Categorical change from baseline DS3 severity status 1, 2, and 5Â years after treatment initiated. Purple color indicates patients for whom data was unavailable for the year evaluated. Mean (SD) ERT doses and range in units/kg body weight/q 2Â weeks are shown beneath the pie charts. Each sub-group includes a few patients in whom treatment was interrupted during an evaluation period and some patients were treated at very low dosesBack to article page